Did the original diagnostic criteria for arthrochalasia-type Ehlers‑Danlos syndrome require congenital bilateral hip dislocation, and have those criteria been revised to no longer require it?

Diagnostic Criteria Evolution for Arthrochalasia-Type Ehlers-Danlos Syndrome

Yes, the original diagnostic criteria for arthrochalasia-type EDS (aEDS) required congenital bilateral hip dislocation as a defining feature, but the 2017 revised international classification has made this criterion less absolute, recognizing that the phenotype can vary and that unilateral or absent hip dislocation does not exclude the diagnosis.

Historical Context and Criteria Evolution

The 1998 Villefranche nosology 1 established arthrochalasia EDS (formerly types VIIA and VIIB) with congenital bilateral hip dislocation as a cardinal feature. Your understanding is correct—the early cases that defined this subtype prominently featured babies with bilateral hip dislocations, which became embedded in the diagnostic framework 2, 3.

Original Diagnostic Features (1998 Villefranche)

The classic presentation included 2, 3:

• Congenital bilateral hip dislocation (considered nearly pathognomonic)
• Severe generalized joint hypermobility with multiple dislocations
• Muscular hypotonia
• Skin hyperextensibility and fragility
• Distinct dysmorphic facial features

The 2017 Revised Classification

The 2017 international classification 4 represents a paradigm shift, moving from purely clinical criteria to a molecular-genetic framework. This revision acknowledges that:

Key Changes in Diagnostic Approach

1. Molecular confirmation is now definitive for aEDS diagnosis (except for hypermobile EDS)
2. Clinical criteria are "suggestive" rather than absolute requirements
3. Phenotypic variability is explicitly recognized, with presentations ranging from severe neonatal forms to milder variants 5, 6

Why This Matters Clinically

The evidence shows significant phenotypic heterogeneity:

• Some patients with confirmed COL1A1 or COL1A2 mutations (the genetic hallmark of aEDS) present with unilateral hip dislocation or even no hip dislocation 5, 6
• The homozygous COL1A1 p.(Glu684Lys) variant demonstrates a spectrum from severe neonatal respiratory distress to classical EDS-like presentations 6
• Timing of diagnosis varies from prenatal detection to adult age, with features becoming less distinct over time 2

Current Diagnostic Framework

The diagnosis now prioritizes molecular findings over rigid clinical checklists:

Molecular Basis (Definitive)

• Heterozygous splice-site variants in COL1A1 or COL1A2 causing exon 6 skipping (most common)
• Rare autosomal recessive missense variants (e.g., COL1A1 p.Glu684Lys) 6
• Results in defective N-proteinase cleavage site on type I procollagen

Clinical Features (Suggestive, Not Required)

• Severe generalized joint hypermobility
• Congenital hip dislocation (bilateral or unilateral)
• Multiple joint dislocations
• Muscular hypotonia (especially prominent in infancy)
• Skin hyperextensibility and fragility
• Craniofacial dysmorphism

Clinical Pitfalls to Avoid

1. Don't exclude aEDS based solely on absent bilateral hip dislocation if other features and molecular findings are consistent 5, 6

2. Beware of misdiagnosis as neuromuscular disorders in neonates—the severe hypotonia can mislead clinicians away from considering connective tissue disease 2, 6

3. Recognize age-dependent presentation: Hypotonia decreases and facial features become less distinct with age, making diagnosis more challenging in older children and adults 2

4. Understand the differential diagnosis complexity: There is significant overlap with other hypermobility syndromes, particularly in the neonatal period when features are most critical to recognize 2

Why the Revision Was Necessary

The shift reflects several realities:

• Genetic heterogeneity: Multiple mutations can produce similar but not identical phenotypes
• Phenotypic variability: Even within the same genetic defect, clinical severity varies considerably 5, 6
• Diagnostic precision: Molecular confirmation provides certainty that clinical criteria alone cannot achieve 4
• Avoiding missed diagnoses: Rigid criteria excluded patients who would benefit from appropriate management and genetic counseling

The bottom line: While congenital bilateral hip dislocation remains a highly characteristic feature of aEDS, it is no longer an absolute requirement for diagnosis when molecular testing confirms the underlying collagen defect. The 2017 criteria appropriately recognize that genetics, not a single clinical feature, defines the condition 4, 5.